Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak
- Conditions
- Chronic PainRheumatic DiseasesRheumatoid ArthritisSars-CoV2
- Interventions
- Other: questionnaire assesment
- Registration Number
- NCT04351399
- Lead Sponsor
- University Hospital, Lille
- Brief Summary
Clinical data about psychological impact of quarantine are well studied in transient event or more prolonged situation like jail incarceration.
In recent metaanalysis, psychological impact of quarantine was well documented in a specific population during first SARS epidemy. Even after the end of quarantine several patients were still with symptom of avoiding mainly agoraphobia, frequent hand washing and a carefull return to normal life COVID-19 infection is already associated with psychological symptom like anxiety, depression, sleep disorders and symptoms of acute stress However psychological impact of quarantine is on none in chronic painful inflammatory rheumatism in France. The prevalence of rheumatoid arthritis is 0.5% of the population with frequent comorbidity such as anxiety and depression.
During the quarantine secondary to COVID-19 pandemic it's possible to evaluated the psychological impact of adult RA patients.
The present study is an "emergency" being realize before the end of the quarantine.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 318
- Rheumatoid arthritis Quarantine
- Non adult patient RA patient without quarantine
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description patient with chronic painful inflammatory rheumatism questionnaire assesment -
- Primary Outcome Measures
Name Time Method Frequency of RA patients with emotional impact (feeling of isolation) maximum 1 week from baseline on
- Secondary Outcome Measures
Name Time Method self-reported questionnaire for painful maximum 1 week from baseline on Self reported questionnaire with questions to assess the characteristic,intensity of pain on quality of life, and consumption of analgesic.
Trial Locations
- Locations (1)
Hopital Roger Salengro, CHU Lille
🇫🇷Lille, France